Brian C. Stephenson - 16 May 2022 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Title: Secretary, Treasurer and Chief Financial Officer
Signature
/s/ Brian C. Stephenson
Issuer symbol
BBIO
Transactions as of
16 May 2022
Net transactions value
-$62,197
Form type
4
Filing time
18 May 2022, 16:06:03 UTC
Previous filing
18 Mar 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Options Exercise +26,680 +8.7% 333,035 16 May 2022 Direct F1
transaction BBIO Common Stock Tax liability $62,197 -9,228 -2.8% $6.74* 323,807 16 May 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BBIO Restricted Stock Units Options Exercise $0 -1,710 -11% $0.000000 13,678 16 May 2022 Common Stock 1,710 Direct F1, F3
transaction BBIO Restricted Stock Units Options Exercise $0 -778 -8.3% $0.000000 8,559 16 May 2022 Common Stock 778 Direct F1, F4
transaction BBIO Restricted Stock Units Options Exercise $0 -24,192 -12% $0.000000 169,351 16 May 2022 Common Stock 24,192 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 26,680 shares of Common Stock underlying the Reporting Person's RSUs.
F3 The RSUs vest in sixteen quarterly installments after May 16, 2020, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F4 The RSUs vest in sixteen quarterly installments after February 16, 2021, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date, and have no expiration date.
F5 The RSUs vest with respect to 1/8th of the underlying shares on May 16, 2022. Thereafter, 1/8th of the underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on February 16, 2024, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Remarks:

Title: Secretary, Treasurer and Chief Financial Officer